Researchers found that exosomes derived from human umbilical cord stem cells can significantly improve liver health in older mice. These tiny vesicles, which are released by stem cells, help enhance a crucial cellular cleaning process known as autophagy while reducing cellular aging markers. As a result, the liver function and metabolic profiles of older mice treated with these exosomes became more similar to those of younger mice, suggesting a potential pathway for combating age-related liver diseases.

This discovery is particularly relevant for anyone concerned about maintaining liver health as they age. Non-alcoholic fatty liver disease (NAFLD) is a common condition that can lead to serious health issues, including liver failure. In the study, older mice that received the exosome treatment showed improvements in key liver health markers, such as lower levels of liver enzymes and reduced fat accumulation. These changes could translate to better metabolic health, potentially benefiting people looking to preserve their liver function and overall well-being into older age.

The research is still in its early stages, conducted on male mice, and while the results are promising, they are not yet proven in humans. The study highlights the role of a specific protein, THBS1, in the effectiveness of these exosomes. Although this approach shows potential, more research is needed to determine if similar benefits can be achieved in humans and to explore the safety and efficacy of such treatments.

For now, focusing on a balanced diet, regular exercise, and avoiding excessive alcohol consumption can help support liver health. Staying informed about emerging therapies like stem cell-derived exosomes may also be beneficial as research progresses.

Source: lifespan.io